1-3 of 3
Jose A Hernández-Hernández, PhD
Close
Sort by
Journal Articles

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Luis Villela M, Ana Ramirez-Ibarguen, MD, Brady E. Beltrán, MD, Victoria Otero, MD, Denisse A. Castro, MD, Myrna Candelaria, MDPharmD, Fernando Pérez-Jacobo, MD, Efreen Montaño Figueroa, PhD, Camila Peña, MD, Sally Rose Paredes, MD, Carlos Best, MD, Andrés Gómez-De León, MD, David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Henry Idrobo, MD, Virginia Abello, MD, Pilar León, MD, Jose A Hernández-Hernández, PhD, Yocanxochitl Perfecto, PhD, Melani Otañez, MD, Sergio Tena, MD, Silvia Rivas-Vera, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1613.
https://doi.org/10.1182/blood-2019-123841
Published: 2019
Journal Articles

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Denisse A. Castro, MD, Brady E. Beltrán, MD, Luis Villela M, Marialejandra Torres Viera, MD, Victoria Otero, MD, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Christine Rojas, MD, Ivan Perdomo, MD, Pilar León, MD, Karen Lalupu, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramirez-Ibarguen, MD, David Gomez-Almaguer, MD, Jose A Hernández-Hernández, PhD, Myrna Candelaria, MDPharmD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Andrés Gómez-De León, MD, Efreen Montaño Figueroa, PhD, Melani Otañez, MD, Carlos Best, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4121.
https://doi.org/10.1182/blood-2019-127479
Published: 2019
Journal Articles

GPX3 Level in Serum of Diffuse Large B Cell Lymphoma Patients Is a Predictive Biomarker for Refractoriness Before Treatment

Luis Villela, MD, Oscar Fajardo, MSc, Darinka Leon, MD, Jose A Hernandez-Hernandez, PhD, Sean Scott, PhD, Sergio Encarnacion, PhD
Journal: Blood
Blood (2012) 120 (21): 5102.
https://doi.org/10.1182/blood.V120.21.5102.5102
Published: 2012